CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 152 enrolled
Drug / intervention
Wingspan Stent Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02034058
NCT02034058N/ACompleted
CompareCT.gov

WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study

Stryker Neurovascular·interventional·Posted Jan 13, 2014·Updated Dec 2, 2019

In Brief

A clinical study evaluating Wingspan Stent System for Intracranial Atherosclerosis. Completed, enrolled 152 participants across 26 sites.

Detailed Summary

The primary objective of this study is to evaluate the rate of stroke and/or death in patients treated with the Wingspan Stent System, according to the Indications for Use, within 72 hours post procedure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntracranial Atherosclerosis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 13, 2014
Enrollment StartDec 1, 2013
Primary CompletionAug 1, 2019
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 12.5 years ago

Interventions

Wingspan Stent Systemdevice

The Wingspan Stent System is used with the Gateway PTA Balloon Catheter. The Wingspan Stent System is a self-expanding, Nitinol stent and delivery system intended for use in the treatment of intracranial atherosclerotic disease. The Gateway PTA Balloon Catheter is an over-the-wire balloon catheter intended for the pre-dilation of the lesion prior to insertion and deployment of the Wingspan Stent System.